Legend Biotech’s shares tumbled 16% Tuesday following the CAR-T company’s third-quarter earnings report, marking a rocky debut for newly installed CEO Ingrid Zhang. | Legend Biotech’s shares tumbled 16% Tuesday following the CAR-T company’s third-quarter earnings report, marking a rocky debut for newly installed CEO Ingrid Zhang.